Literature DB >> 29311130

MRAS: A Close but Understudied Member of the RAS Family.

Lucy C Young1, Pablo Rodriguez-Viciana2.   

Abstract

MRAS is the closest relative to the classical RAS oncoproteins and shares most regulatory and effector interactions. However, it also has unique functions, including its ability to function as a phosphatase regulatory subunit when in complex with SHOC2 and protein phosphatase 1 (PP1). This phosphatase complex regulates a crucial step in the activation cycle of RAF kinases and provides a key coordinate input required for efficient ERK pathway activation and transformation by RAS. MRAS mutations rarely occur in cancer but deregulated expression may play a role in tumorigenesis in some settings. Activating mutations in MRAS (as well as SHOC2 and PP1) do occur in the RASopathy Noonan syndrome, underscoring a key role for MRAS within the RAS-ERK pathway. MRAS also has unique roles in cell migration and differentiation and has properties consistent with a key role in the regulation of cell polarity. Further investigations should shed light on what remains a relatively understudied RAS family member.
Copyright © 2018 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29311130     DOI: 10.1101/cshperspect.a033621

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  9 in total

1.  Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven Cancers.

Authors:  Rita Sulahian; Jason J Kwon; Katherine H Walsh; Emma Pailler; Timothy L Bosse; Maneesha Thaker; Diego Almanza; Joshua M Dempster; Joshua Pan; Federica Piccioni; Nancy Dumont; Alfredo Gonzalez; Jonathan Rennhack; Behnam Nabet; John A Bachman; Amy Goodale; Yenarae Lee; Mukta Bagul; Rosy Liao; Adrija Navarro; Tina L Yuan; Raymond W S Ng; Srivatsan Raghavan; Nathanael S Gray; Aviad Tsherniak; Francisca Vazquez; David E Root; Ari J Firestone; Jeff Settleman; William C Hahn; Andrew J Aguirre
Journal:  Cell Rep       Date:  2019-10-01       Impact factor: 9.423

2.  Polycistronic baculovirus expression of SUGT1 enables high-yield production of recombinant leucine-rich repeat proteins and protein complexes.

Authors:  Kelly Snead; Vanessa Wall; Hannah Ambrose; Dominic Esposito; Matthew Drew
Journal:  Protein Expr Purif       Date:  2022-02-04       Impact factor: 1.650

3.  Structure of the SHOC2-MRAS-PP1C complex provides insights into RAF activation and Noonan syndrome.

Authors:  Daniel A Bonsor; Patrick Alexander; Kelly Snead; Nicole Hartig; Matthew Drew; Simon Messing; Lorenzo I Finci; Dwight V Nissley; Frank McCormick; Dominic Esposito; Pablo Rodriguez-Viciana; Andrew G Stephen; Dhirendra K Simanshu
Journal:  Nat Struct Mol Biol       Date:  2022-09-29       Impact factor: 18.361

4.  Determination of WWOX Function in Modulating Cellular Pathways Activated by AP-2α and AP-2γ Transcription Factors in Bladder Cancer.

Authors:  Damian Kołat; Żaneta Kałuzińska; Andrzej K Bednarek; Elżbieta Płuciennik
Journal:  Cells       Date:  2022-04-19       Impact factor: 7.666

Review 5.  Rho and Rab Family Small GTPases in the Regulation of Membrane Polarity in Epithelial Cells.

Authors:  Klaus Ebnet; Volker Gerke
Journal:  Front Cell Dev Biol       Date:  2022-07-04

6.  Advancing RAS/RASopathy therapies: An NCI-sponsored intramural and extramural collaboration for the study of RASopathies.

Authors:  Andrea M Gross; Megan Frone; Karen W Gripp; Bruce D Gelb; Lisa Schoyer; Lisa Schill; Beth Stronach; Leslie G Biesecker; Dominic Esposito; Edjay Ralph Hernandez; Eric Legius; Mignon L Loh; Staci Martin; Deborah K Morrison; Katherine A Rauen; Pamela L Wolters; Dina Zand; Frank McCormick; Sharon A Savage; Douglas R Stewart; Brigitte C Widemann; Marielle E Yohe
Journal:  Am J Med Genet A       Date:  2020-01-08       Impact factor: 2.578

7.  Classical RAS proteins are not essential for paradoxical ERK activation induced by RAF inhibitors.

Authors:  Lick Pui Lai; Nicole Fer; William Burgan; Vanessa E Wall; Bingfang Xu; Daniel Soppet; Dominic Esposito; Dwight V Nissley; Frank McCormick
Journal:  Proc Natl Acad Sci U S A       Date:  2022-02-01       Impact factor: 12.779

8.  Uncovering Oncogenic Mechanisms of Tumor Suppressor Genes in Breast Cancer Multi-Omics Data.

Authors:  Seong Beom Cho
Journal:  Int J Mol Sci       Date:  2022-08-25       Impact factor: 6.208

9.  GNG2 acts as a tumor suppressor in breast cancer through stimulating MRAS signaling.

Authors:  Anjiang Zhao; Dan Li; Xiongmin Mao; Mengliu Yang; Wuquan Deng; Wenjing Hu; Chen Chen; Gangyi Yang; Ling Li
Journal:  Cell Death Dis       Date:  2022-03-23       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.